Interferon alfa-2a clinical studies: Revision history

9 January 2014

• curprev 14:0514:05, 9 January 2014‎ ShiSheng talk contribs‎ 1,236 bytes −10,519‎ No edit summary

6 January 2014

• curprev 01:3301:33, 6 January 2014‎ ShiSheng talk contribs‎ 11,755 bytes +1‎ →‎Chronic hepatitis B Studies 8 and 9: PEGASYS Monotherapy
• curprev 01:3201:32, 6 January 2014‎ ShiSheng talk contribs‎ 11,754 bytes −1‎ →‎Chronic hepatitis B Studies 8 and 9: PEGASYS Monotherapy
• curprev 01:3101:31, 6 January 2014‎ ShiSheng talk contribs‎ 11,755 bytes −24‎ →‎Chronic hepatitis B Studies 8 and 9: PEGASYS Monotherapy
• curprev 01:2901:29, 6 January 2014‎ ShiSheng talk contribs‎ 11,779 bytes +10,635‎ →‎Clinical Studies

5 January 2014

• curprev 23:5623:56, 5 January 2014‎ ShiSheng talk contribs‎ 1,144 bytes +1,144‎ Created page with "__NOTOC__ {{Interferon alfa-2a}} {{CMG}} ==Clinical Studies== Studies have shown that Roferon-A can normalize serum ALT, improve liver histology and reduce viral load in p..."